Studies on the mechanism of leukotriene B4 biosynthesis in suspensions composed of neutrophils plus erythrocytes indicate that human erythrocytes convert neutrophil-derived leukotriene A4 into leukotriene B4. Leukotriene B4 formation by neutrophils in the presence of erythrocytes exceeded that from corresponding suspensions of neutrophils alone. The increase was proportional to the erythrocyte content of the suspension. The erythrocyte-dependent increase in leukotriene B4 biosynthesis did not equal the arithmetic sum of calcium ionophore-dependent biosynthesis by neutrophils plus calcium ionophore-dependent biosynthesis by erythrocytes, since erythrocytes produced no leukotriene B4 upon incubation with ionophore A23187. Erythrocytes did not stimulate 5-lipoxygenase activity within neutrophils, since the erythrocyte effect was confined to enzymatic hydration: leukotriene B4 increased coincident with decreased formation of 5,12-dihydroxyicosatetraenoic acids derived from nonenzymatic hydration. Biosynthesis of leukotriene B4 within the erythrocyte, from neutrophil-derived leukotriene A4, was established by comparing the effect of normal erythrocytes with erythrocytes containing a leukotriene A4 hydrolase that was inactivated by the substrate. In the latter case, leukotriene B4 formation increased by only 30-40%; in the former case, it increased by 100-200%. Transcellular biosynthesis of leukotriene B4 from erythrocyte-neutrophil interactions (i) explains the paradoxical presence of leukotriene A4 hydrolase within erythrocytes, a cell incapable of synthesizing leukotriene A4; (u) affords a mechanism to overcome rate limitations or "suicide inactivation" of leukotriene A4 hydrolase in neutrophils; (iii) exploits a cryptic capacity within erythrocytes, provisionally dormant cells in terms of icosanoid biosynthesis; (iv) indicates that the biosynthetic capacity of cell combinations is not necessarily equivalent to the sum of their separate capacities.
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Enzymatic cooperation between separate cell types may be a significant, but neglected, mechanism for the biosynthesis of certain prostaglandins or leukotrienes. This concept originated from studies on platelet-endothelial cell interactions, which showed that prostaglandin I2 (PGI2), an antithrombotic icosanoid, was produced by endothelial cells from plateletderived prostaglandin endoperoxide H2 (1) (2) (3) (4) (5) . Analogous transcellular biosynthetic processes are conceivable for other cell combinations and for other arachidonic acid metabolites; however, few biologically relevant examples exist. Requirements for this process include "acceptor" cells with a constitutive enzymatic capacity for the formation of a biologically active icosanoid product but a deficient, or disabled, capacity for substrate generation, plus auxiliary "donor" cells that can fulfill that corresponding substrate requirement. In this context, neutrophil-erythrocyte interactions attracted our attention as potential sources for transcellular biosynthesis of leukotrienes (6) .
Ordinarily (8, 9) . Erythrocytes, by contrast, lack a demonstrable capacity for biosynthesis of LTA4, yet they have a paradoxical capacity to convert it, when available, into LTB4 (6) . We aimed to determine whether human erythrocytes could produce the chemotactic myotropic agent LTB4 from neutrophil-derived LTA4.
MATERIALS AND METHODS
Materials. Synthetic LTA4 methyl ester (Upjohn) was purified prior to use (10); LTA4 lithium salt was prepared as described (11) . Synthetic leukotrienes and prostaglandin B1 (PGB1; Upjohn) and microcrystalline cellulose, a-cellulose, and calcium ionophore A23187 (Sigma) were used as received. Water, ethyl acetate, and methanol, all distilled in glass (Burdick and Jackson, Muskegon, MI), and C18 reversed-phase HPLC (RP-HPLC) columns (250 x 6 x 4 mm) (Rainen Instruments, Woburn, MA) were used for metabolite isolation and quantification.
Preparation of Purified Human Erythrocyte Suspensions. Human venous blood (50 ml) collected in sterile 3.8% (wt/vol) sodium citrate (5.5 ml) was centrifuged at 200 X g for 30 min, and the platelet-rich plasma was removed. Sedimented erythrocytes, leukocytes, and platelets were resuspended in sterile 0.9% (wt/vol) NaCl (50 ml) and centrifuged at 200 x g for 20 min. The supernatant was discarded. After two washes the cell suspension was depleted of residual leukocytes and platelets by filtration through columns containing microcrystalline cellulose and a-cellulose (1:1, wt/wt) (12) . Erythrocytes were resuspended at 2 x 109 cells per ml. The purified erythrocyte suspension contained -5 x 104 leukoAbbreviations: LTB4 and LTA4, leukotriene B4 and A4; diHETE, dihydroxyicosatetraenoic acid; PGI2 and PGB1, prostaglandin I2 and B1; RP-HPLC, reversed-phase HPLC. *To whom reprint requests should be addressed.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. cytes per ml and <5 x 106 platelets per ml. Differential cell counts were determined with a Coulter Diffz system. sequester metabolites of synthetic LTA4. The content of LTB4 in the supernatant was determined as described (6) , and the erythrocytes were resuspended in 0.9% (wt/vol) NaCl (2 x 109 cells per ml). The extent of suicide inactivation of LTA4 epoxide hydrolase in erythrocytes was determined by comparing LTB4 biosynthesis from control erythrocytes incubated with 10 uM LTA4 to LTB4 biosynthesis from suicideinactivated erythrocytes incubated with 10 uM LTA4. Transcellular metabolism of LTA4 from neutrophils stimulated with 5 ,uM A23187 was characterized as described above. Control erythrocytes were compared to erythrocytes with suicide-inactivated LTA4 epoxide hydrolase to establish the involvement of erythrocytes as acceptor cells for LTA4 donated by neutrophils.
RESULTS
Human neutrophils stimulated with calcium ionophore A23187 produced three 5,12-diol metabolites of LTA4, including the enzymatic hydration product LTB4 and the two nonenzymatic products (5S,12R)-5,12-dihydroxy-6,8,10-trans-14-cis-icosatetraenoic acid (peak I) and (5S,12S)-5,12-dihydroxy-6,8,10-trans-14-cis-icosatetraenoic acid (peak II) (Fig. LA) , consistent with the established characteristics of these cells (7) . Human erythrocytes incubated with A23187 did not produce detectable amounts of these or other leukotrienes, confirming that erythrocytes alone did not synthesize LTA4 from endogenous arachidonic acid (Fig.  1C) . When erythrocytes and neutrophils together were incubated with A23187, LTB4 biosynthesis increased with a corresponding decrease in the formation of nonenzymatic isomers I and II, relative to suspensions of neutrophils alone (Fig. 1B) (Fig. 3) .
Results in Figs. [1] [2] [3] suggested that the erythrocyte-dependent increase in LTB4 biosynthesis occurred by transcellular (14) . Our model for transcellular metabolism predicts that suicide inactivation of epoxide hydrolase by exposure of erythrocytes to synthetic LTA4 would diminish their capacity to produce LTB4 upon subsequent exposure to neutrophil-derived LTA4. Our results confirm this prediction. Neutrophils alone incubated with 5 ,uM A23187 produced 0.606 ± 0.040 nmol of LTB4 (mean ± SEM, n = 8); neutrophils plus autologous control erythrocytes produced 1.29 ± 0.060 nmol of LTB4; and neutrophils plus autologous erythrocytes with an epoxide hydrolase that had been inactivated by prior exposure to 10
,uM LTA4 produced 0.83 ± 0.050 nmol of LTB4. Thus, the relative increase in LTB4 biosynthesis was 0.68 nmol of LTB4 (Fig. 4) , or 112%, with normal erythrocytes, which may be compared to 0.22 nmol of LTB4, or 37%, with erythrocytes containing suicide-inactivated LTA4 hydrolase. Control experiments with two successive additions of synthetic LTA4
confirmed that erythrocytes were suicide inactivated by the first addition of synthetic LTA4 (Fig. 4) . It was noteworthy that nonenzymatic hydration products were relatively constant, or slightly increased, in suspensions of suicide-inactivated erythrocytes, indicating that the 5-lipoxygenase enzyme in neutrophils was not inactivated. LTB4 levels in suspensions containing erythrocytes remained high for at least 20 min. For example, at 5, 10, and 20 min, suspensions of neutrophils alone (1.5 x 107 cells per ml) contained 0.56, 0.46, and 0.21 nmol of LTB4, which may be compared to 1.25, 1.25, and 0.87 nmol of LTB4 in corresponding suspensions containing 6.4 x 108 erythrocytes per ml. 
DISCUSSION
Collectively, these results demonstrate that transcellular biosynthesis ofLTB4 occurs along an erythrocyte-neutrophil axis. Neutrophils can produce and release both LTB4 and LTA4; erythrocytes can convert a portion of neutrophilderived LTA4 into additional LTB4. Certain points support this conclusion. First, the erythrocyte-dependent increase in LTB4 biosynthesis did not originate from the arithmetic sum of ionophore stimulation of neutrophil arachidonic acid metabolism plus ionophore stimulation of erythrocyte arachidonic acid metabolism. Human erythrocytes, lacking detectable phospholipase A2 and 5-lipoxygenase activity, did not produce LTB4 or related LTA4 metabolites upon stimulation with ionophore A23187. Second, the increase in LTB4 formation did not originate from erythrocyte-dependent stimulation of neutrophil metabolism. If Our results on erythrocyte-neutrophil interactions and transcellular biosynthesis provide one plausible explanation for the otherwise paradoxical presence of LTA4 epoxide hydrolase within human erythrocytes. Furthermore, transcellular biosynthesis of LTB4 affords a mechanism to supersede rate limitations or suicide inactivation within the neutrophil, and to recruit a provisionally inactive cell, the erythrocyte, for active contributions to leukotriene formation. The cellular and enzymatic traits that permit transcellular biosynthesis from erythrocyte-neutrophil interactions also facilitated a rigorous evaluation ofthe hypothesis. These traits include the compartmentalization of phospholipase and 5-lipoxygenase activities within neutrophils but not erythrocytes, the susceptibility of LTA4 hydrolase to suicide inactivation, and the hydration of LTA4 by both enzymatic and nonenzymatic processes. These or comparable traits may be useful for identifying other model systems of cell-cell interactions.
It is interesting to compare erythrocyte-neutrophil interactions with existing examples of transcellular metabolism of icosanoids. For instance, platelet-neutrophil interactions can also increase LTB4 biosynthesis and form (5S,12S)-diHETE and 12,20-diHETE (15-18) products of uncertain biological significance. In contrast, neutrophil-erythrocyte interactions increase only LTB4, a leukotriene with chemotactic and myotropic effects (19) . Platelet-endothelial cell interactions yield PGI2, an antithrombotic substance, but proofs that PG12 originates from platelet-derived prostaglandin H2 have depended upon the use of pharmacological agents to modify platelet thromboxane synthetase or endothelial cell cyclooxygenase. In contrast, a transcellular origin for LTB4 and a need for such an origin can be established exclusively in terms of cellular, enzymatic, and chemical attributes of erythrocyte and neutrophil LTA4 hydrolase. The biological significance of transcellular metabolism remains to be established, but our results support Marcus' advocacy for cell-cell interactions as an important but novel form of icosanoid biosynthesis (3, 16) . Since cell combinations encountered in disease may differ from those encountered in normal circumstances the study of transcellular metabolism assumes some significance (20) . An 
